Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.5M | $11.0M | $8.1M | $7.0M | $6.8M | $5.9M | $5.5M | $5.1M | $4.3M | $8.7M | $16.5M | $19.6M | $20.3M | $17.9M | $17.5M | $14.2M | $9.2M |
| Gross profit | $8.8M | $8.0M | $6.0M | $5.1M | $4.9M | $4.1M | $3.6M | $3.1M | $2.4M | $3.5M | $6.2M | $6.6M | $7.5M | $5.2M | $6.9M | $6.0M | $4.0M |
| Research & development | $1.1M | $1.0M | $875,000 | $845,000 | $739,000 | $619,000 | $559,000 | $542,000 | $518,000 | $927,000 | — | $2.7M | $4.3M | $6.6M | $3.0M | $965,000 | $457,000 |
| Operating expenses | $6.8M | $6.1M | $5.9M | $5.7M | $4.9M | $4.4M | $4.3M | $4.5M | $4.4M | $6.6M | $11.3M | $16.8M | $28.9M | $26.0M | $14.9M | $12.6M | $6.2M |
| Operating income | $2.0M | $1.9M | $74,000 | −$629,000 | −$8,000 | −$310,000 | −$699,000 | −$1.4M | −$1.9M | −$3.1M | −$5.2M | −$10.2M | −$21.3M | −$20.7M | −$8.0M | −$6.5M | −$2.3M |
| EBITDAderived | $2.1M | $2.1M | $235,000 | −$507,000 | $67,000 | −$288,000 | −$643,000 | −$1.3M | −$1.8M | −$2.9M | −$4.9M | −$9.5M | −$20.3M | −$19.3M | −$7.2M | −$5.9M | −$2.1M |
| Net income | $2.5M | $6.3M | $119,000 | −$633,000 | −$21,000 | $69,000 | −$618,000 | −$2.0M | −$1.2M | $145,000 | −$10.6M | −$27.1M | −$29.7M | −$16.7M | $35.4M | −$25.1M | −$5.8M |
| Basic EPSper diluted share | $1.01 | $2.53 | $0.05 | -$0.25 | $0.00 | $0.00 | -$0.02 | -$0.07 | -$0.04 | $0.01 | -$0.40 | -$1.19 | -$1.57 | -$0.93 | $2.03 | -$1.68 | -$500.00 |
| Diluted EPSper diluted share | $0.99 | $2.51 | $0.05 | -$0.25 | $0.00 | $0.00 | -$0.02 | -$0.07 | -$0.04 | $0.01 | -$0.40 | -$1.19 | -$1.57 | -$0.93 | $1.99 | -$1.68 | — |